Characteristics and outcomes of gemcitabine-associated pulmonary hypertension.
Mouillot P, Favrolt N, Khouri C, Grandvuillemin A, Chaumais MC, Schenesse D, Seferian A, Jais X, Savale L, Beltramo G, Sitbon O, Cracowski JL, Humbert M, Georges M, Bonniaud P, Montani D.
Mouillot P, et al.
ERJ Open Res. 2024 May 20;10(3):00654-2023. doi: 10.1183/23120541.00654-2023. eCollection 2024 May.
ERJ Open Res. 2024.
PMID: 38770007
Free PMC article.